|
Quotes & Info
|
| OCR > SEC Filings for OCR > Form 8-K on 29-Nov-2012 | All Recent SEC Filings |
29-Nov-2012
Entry into a Material Definitive Agreement, Other Events
On November 29, 2012, Omnicare, Inc. (the "Company") entered into an accelerated
share repurchase agreement (the "ASR Agreement") with Goldman, Sachs & Co.
("Goldman") pursuant to which the Company will repurchase $250 million of its
outstanding common stock.
Pursuant to the ASR Agreement, the Company will make a $250 million payment to
Goldman on November 30, 2012 and will receive an initial number of approximately
5.8 million shares of its outstanding common stock from Goldman on the same day.
The specific number of shares that the Company ultimately will repurchase under
the ASR Agreement will be based generally on the average of the daily
volume-weighted average price per share of the Company's common stock during a
repurchase period, subject to adjustments pursuant to the terms and conditions
of the ASR Agreement. At settlement, under certain circumstances, Goldman may be
required to deliver additional shares of common stock to the Company, or, under
certain circumstances, the Company may be required to deliver shares of its
common stock or may elect to make a cash payment to Goldman. The ASR Agreement
contains provisions customary for agreements of this type, including provisions
for adjustments to the transaction terms, the circumstances generally under
which the ASR Agreement may be accelerated, extended or terminated early by
Goldman and various acknowledgements, representations and warranties made by the
parties to one another. The transaction is expected to be completed during the
first half of 2013.
The Company entered into the ASR Agreement pursuant to, and as part of, the Company's previously disclosed share repurchase program, most recently authorized by its board of directors on September 12, 2012. As of September 30, 2012, the Company had approximately $498 million of share repurchase authority remaining.
On November 28, 2012, the Company terminated its 10b5-1 stock buying plan entered into on February 29, 2012.
|
|